Lobe Sciences Ltd. (LOBEF)

Lobe Sciences Cash Flow Statement

Financials in millions CAD. Fiscal year is September - August.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Net Income	-4.42	-4.71	-12.25	-9.66	-3.44
Depreciation & Amortization	0.08	0.04	0.01	-	-
Other Amortization	-	0.03	-	-	-
Asset Writedown & Restructuring Costs	2.59	-	-	7.35	-
Loss (Gain) From Sale of Investments	-	0.66	0.2	0.46	-
Loss (Gain) on Equity Investments	-	0.02	0.28	0.09	-
Stock-Based Compensation	0.27	0.3	0.62	1.04	0.74
Provision & Write-off of Bad Debts	-	-	-	0.06	0.91
Other Operating Activities	-0.32	0.41	7.56	-4.85	-0.23
Change in Accounts Receivable	0.01	0	0.18	-0.14	0.11
Change in Inventory	0	0.02	-	-	-
Change in Accounts Payable	1.15	1.32	0.5	0.24	0.2
Change in Income Taxes	0.03	0.21	-	-	-
Change in Other Net Operating Assets	0.14	-0.04	0.17	0.09	0.01
Operating Cash Flow	-0.46	-1.72	-2.73	-5.04	-1.22
Sale of Property, Plant & Equipment	-	-	-	1.65	0.2
Sale (Purchase) of Intangibles	-	-	-	-0.14	-
Investment in Securities	-	-	-	-0.45	-
Investing Cash Flow	-	-	-	1.07	0.2
Long-Term Debt Issued	0.56	0.34	-	-	-
Long-Term Debt Repaid	-	-	-	-0.09	-0.16
Net Debt Issued (Repaid)	0.56	0.34	-	-0.09	-0.16
Issuance of Common Stock	-	0.72	2.54	5.2	0.89
Other Financing Activities	-	-0.1	-0.04	-0.2	-0.01
Financing Cash Flow	0.56	0.95	2.5	4.92	0.72
Foreign Exchange Rate Adjustments	-0	0	-	0.02	-0.04
Net Cash Flow	0.1	-0.77	-0.23	0.97	-0.34
Levered Free Cash Flow	-1.5	-0.92	0.52	-3.97	-0.94
Unlevered Free Cash Flow	-1.39	-0.89	0.52	-3.97	-0.94
Change in Net Working Capital	0.41	-0.83	-2.47	0.89	-0.58

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.